Email updates

Keep up to date with the latest news and content from BMC Biotechnology and BioMed Central.

Open Access Open Badges Research article

Bipartite and tripartite Cucumber mosaic virus-based vectors for producing the Acidothermus cellulolyticus endo-1,4-β-glucanase and other proteins in non-transgenic plants

Min Sook Hwang1, Benjamin E Lindenmuth23, Karen A McDonald2 and Bryce W Falk1*

Author affiliations

1 Department of Plant Pathology, University of California, One Shields Avenue, Davis, CA, 95616, USA

2 Department of Chemical Engineering and Materials Science, University of California, One Shields Avenue, Davis, CA, 95616, USA

3 Present address: Bayer HealthCare Pharmaceuticals, 800 Dwight Way, Berkeley, CA, 94710, USA

For all author emails, please log on.

Citation and License

BMC Biotechnology 2012, 12:66  doi:10.1186/1472-6750-12-66

The electronic version of this article is the complete one and can be found online at:

Received:14 June 2012
Accepted:11 September 2012
Published:21 September 2012

© 2012 Hwang et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.



Using plant viruses to produce desirable proteins in plants allows for using non-transgenic plant hosts and if necessary, the ability to make rapid changes in the virus construct for increased or modified protein product yields. The objective of this work was the development of advanced CMV-based protein production systems to produce Acidothermus cellulolyticus endo-1, 4-β-glucanase (E1) in non-transgenic plants.


We used two new Cucumber mosaic virus (CMV)-based vector systems for producing the green fluorescent protein (GFP) and more importantly, the Acidothermus cellulolyticus endo-1, 4-β-glucanase (E1) in non-transgenic Nicotiana benthamiana plants. These are the inducible CMVin (CMV-based inducible) and the autonomously replicating CMVar (CMV-based advanced replicating) systems. We modified a binary plasmid containing the complete CMV RNA 3 cDNA to facilitate insertion of desired sequences, and to give modifications of the subgenomic mRNA 4 leader sequence yielding several variants. Quantitative RT-PCR and immunoblot analysis showed good levels of CMV RNA and coat protein accumulation for some variants of both CMVin and CMVar. When genes for E1 or GFP were inserted in place of the CMV coat protein, both were produced in plants as shown by fluorescence (GFP) and immunoblot analysis. Enzymatic activity assays showed that active E1 was produced in plants with yields up to ~ 11 μg/g fresh weight (FW) for specific variant constructs. We also compared in vitro CMV genomic RNA reassortants, and CMV RNA 3 mutants which lacked the C’ terminal 33 amino acids of the 3A movement protein in attempts to further increase E1 yield. Taken together specific variant constructs yielded up to ~21 μg/g FW of E1 in non-transgenic plants.


Intact, active E1 was rapidly produced in non-transgenic plants by using agroinfiltration with the CMV-based systems. This reduces the time and cost compared to that required to generate transgenic plants and still gives the comparable yields of active E1. Our modifications described here, including manipulating cloning sites for foreign gene introduction, enhance the ease of use. Also, N. benthamiana, which is particularly suitable for agroinfiltration, is a very good plant for transient protein production.

Cucumber mosaic virus; Protein production; Endoglucanase; Agrobacterium tumefaciences; Viral vector; Transient protein expression; Nicotiana benthamiana


Using plant viruses as vehicles for foreign protein production in plants offers many advantages over more traditional prokaryotic-based, and even over transgenic plant-based protein production systems. For example, plants are relatively easy and inexpensive to grow, plants are able to perform post-translational protein modifications (e.g. glycosylation) not possible with prokaryotes, and plant cells can secrete appropriately engineered proteins allowing for simplified product purification [1,2]. Transgenic plants engineered to produce desirable proteins offer some of these advantages, but engineered plants require substantial time, effort and cost to develop and do not offer flexibility for rapid change if modifications to the protein product are desired. By contrast, using plant viruses to produce desired proteins in plants allows for using non-transgenic plant hosts and if necessary, the ability to make rapid changes in the virus construct for increased or modified protein product yields.

Cucumber mosaic virus (CMV) is the one of the viruses that has been used for protein production in plants [3,4]. CMV has an extremely wide plant host range [5] which opens the door for using plants other than only Nicotiana spp. for producing proteins, and thus an optimized CMV-based protein production system would be very desirable. But CMV also has some potential drawbacks for foreign protein production. CMV has a tripartite single-stranded RNA genome and each genomic RNA is packaged separately within icosahedral capsids [5]. CMV genomic RNAs 1 and 2 encode the 1a and 2a proteins, respectively, which are involved in viral RNA replication [5,6]. RNA 2 also encodes a small protein called 2b, which affects virulence and is known to suppress the initiation of the plant defense, RNA silencing, and to play a role in promoting cell-to-cell movement [7]. RNA 3 also is bicistronic, encoding the cell-to-cell movement protein (MP) and the virion capsid protein (CP). All three CMV genomic RNAs are essential for the systemic plant infection and all five CMV-encoded proteins directly or indirectly affect the movement of CMV within the plant host [5]. Still, CMV genome segments 2 and 3 have been modified in some cases for insertion of specific sequences which can give foreign protein production in plants [4,8,9].

In our previous work we engineered a binary plasmid to contain modified complementary DNAs (cDNAs) representing the complete CMV tripartite genome, in which the CMV coat protein gene was replaced by the gene encoding α-1-antitrypsin [AAT] [9]. We deleted a region of the CMV RNA 1 leader sequence to ensure that the viral replicase was not able to replicate the truncated RNA 1 and since coat protein was lacking, infectious CMV was not generated thereby eliminating possible unwanted spread of the recombinant CMV. Furthermore, because one of the key CMV-encoded protein components of the viral replicase (1a) is under the control of a relatively tightly regulated chemically inducible promoter (the XVE inducible promoter [10]), recombinant viral amplicons were produced intracellularly only after addition of the inducer (β-estradiol). The high efficiency and specificity are among the major advantages of the XVE system, and thus it provides a potent tool for research in plant biotechnology.

Despite the advantage of having all CMV components on a single plasmid (e.g. ensuring that all CMV components are simultaneously introduced into the same cell) [9], the CMViva plasmid proved to not be easy for subsequent manipulation. Its size alone (28 kbp) made subsequent cloning manipulations difficult. Therefore, here we explored development of new CMV-based smaller-sized variants by separating genome components onto different plasmids to give a bipartite inducible (CMVin, CMV-based inducible system) and tripartite, autonomously replicating forms of CMV (CMVar, CMV-based advanced replicating system). We also assessed the effects of mRNA4 leader sequence variants and compared two CMV genotypes for their abilities to give in planta production of two proteins, the green fluorescent protein (GFP) and the Acidothermus cellulolyticus endo-1, 4-β-glucanase (E1), a cellulose degrading enzyme. This heat-stable, 56,000 MW well-studied endoglucanase has been produced previously in different species of transgenic plants [11-13], and is believed to have potential application for cellulose biomass conversion to sugars and use in biofuel production. Here we show that active E1 can be rapidly produced in non-transgenic plants by using agroinfiltration with the CMV-based systems. This reduces the time and energy required to generate transgenic plants and still gives the comparable yields of active E1 to those obtained previously by others.


Plants and photography

Three-week-old Nicotiana benthamiana plants and nine day old zucchini squash (Cucurbita pepo L. cv. Green Bush) plants were used for virus inoculations or agroinfiltration. Plants were photographed with a Cannon G6 digital camera equipped with a Tiffen Deep Yellow 15 filter. For photographing GFP expression, plants were illuminated with a hand-held long-wave UV lamp.

Cloning and plasmid construction

In order to develop CMVin (CMV-based inducible system) and CMVar (CMV-based advanced replicating system), the gene-of-interest was inserted into the coat protein coding region of CMV-Q RNA 3 (GenBank:M21464) [14] to give pCMVar RNA 3. We modified the CMV RNA 3 intergenic region, which also gives rise to the mRNA 4 leader sequence, by PCR primer tagging to introduce additional restriction enzyme sites for easier cloning. This was done by PCR amplifying the CP coding region using tagged forward primers (EATG for sequence 2, HATG for sequence 6, PHATG for sequence 8, and CPfwd for the wild type leader sequence, Table 1) and the reverse primer (CPrev listed in Table 1), and GoFlexi Taq DNA polymerase (Promega Corp., Madison, WI, U.S.A.). Amplified fragments were transferred to pGEM-T Easy (Promega Corp., Madison, WI, U.S.A.) and sequences were verified. Plasmids were then digested by Pst I and Tth111 I, and the desired fragment was transferred to pQA3 [9] (Additional file 1: Figure S1). Then sequences containing the CaMV 35S (35S) promoter, RNA 3 and 35S terminator were PCR amplified using primers 35SPfwd and 35STrev (Table 1) and Pfu DNA polymerase (Stratagene, Agilent TechnologiesCompany, U.S.A), and the resulting fragments were ligated into the Sma I site of the mini binary vector, pCB301 [15] (Additional file 1: Figure S1). These were then used as the RNA 3 source for CMVar and CMVin variants. The higher producing constructs (containing the 2, 6, and 8 modified, and wildtype leader sequences of RNA4; Additional file 2: Figure S2) were selected for further experiments.

Additional file 1. Figure S1. Construction of the pCMVar RNA 3 plasmid.

Format: TIFF Size: 1.1MB Download fileOpen Data

Additional file 2. Figure S2. Northern blotting analyses of CMVin II variants.

Format: TIFF Size: 280KB Download fileOpen Data

Table 1. List of primers used here

The E1 sequence (GenBank:HQ541433) used here was first codon-optimized for dicots and constructed to contain the rice alpha amylase (RAmy 3D, GeneBank:M59351) signal peptide at its N’-terminus, and a 6-His tag at its C’ terminus (synthesized by DNA2.0, Menlo Park, CA, webcite, and provided as plasmid DNA pJL201:11772) ([16], see Figure 1A). The green fluorescent protein (GFP) and E1 coding sequences were PCR amplified and cloned into the CP coding region of pCMVar RNA 3.

thumbnailFigure 1. (A) Diagram of the E1 constructs and (B) Modified RNA 4 leader sequences containing restriction enzyme sites compared to unmodified wild type (wt) leader sequences. (A) Gene structure of the E1 used in this report. The E1 gene contains the rice amylase signal peptide in the upstream of its ORF and a 6 histidine-tag in its C-terminus. RAmySP; rice amylase signal sequence. This Figure is not to scale. (B) Restriction endonuclease sequences are shown as italicized and underlined, the CP start codon (AUG) is shown in bold. Modified leader sequences are located between the wildtype leader sequence and AUG start codon in subgenomic RNA4. Wt, wildtype leader sequence; 2+, modified #2 leader sequences addition to the wildtype leader sequence; 6+, modified #6 leader sequences addition to the wildtype leader sequence; 8+, modified #8 leader sequences addition to the wildtype leader sequence.

First, primer sets downstreamfwd and the Rna4wtrev, Rna42rev, Rna46rev, Rna48rev (listed in Table 1), were used for reverse PCR to remove the CP coding region (Additional file 3: Figure S3). The E1 gene was amplified by PCR using specific primers set (endoonlyfwd and endoonlyrev as listed in Table 1) and ligated into coat protein gene-deleted pCMVar RNA 3 by blunt end ligation (Additional file 3: Figure S3), yielding pCMVar E. The GFP coding sequence was PCR amplified from pCMViva GFP [9] using the specific primer sets (GFPfwd and GFPrev listed in Table 1), and cloned into the coat protein region of pCMVar RNA 3 using the same methods as for E1, resulting in pCMVar G (Additional file 3: Figure S3).

Additional file 3. Figure S3. Construction of the pCMVar G and pCMVar E variants for GFP and E1.

Format: TIFF Size: 335KB Download fileOpen Data

To generate the CMVar replicating constructs, CMV RNA 1 and RNA 2 segments (for CMV subgroup I and II) were PCR amplified using the specific forward and reverse primer sets (RNA1fwd and RNA12rev for subgroup II RNA 1, RNA2fwd and RNA12rev for subgroup II RNA 2, IRNA1fwd and IRNA12rev for subgroup I RNA 1, IRNA2fwd and IRNA12rev for subgroup II RNA 2, respectively, as listed in Table 1). The RNA 3 region of pCMVar RNA 3 was removed and replaced by the RNA 1 or 2 genome segments and gave I and II pCMVar RNA 1 and 2 (Additional file 4: Figure S4). The subgroup I RNA 1 and RNA 2 were originally from a California CMV [17], and the subgroup II RNA 1 and RNA 2 were from CMV-Q (GenBank:X02733 for RNA 1, X00985 for RNA 2, respectively).

Additional file 4. Figure S4. Construction of the pCMVar I and II for subgroup I, II RNA 1 & 2.

Format: TIFF Size: 323KB Download fileOpen Data

For the CMVin system, RNA 1 and 2 segments came from pDUXLR1R2 (pR1R2; [9] which includes the modified RNA 1 sequence. The monopartite inducible CMViva expression system, pCMV containing all three CMV genomic RNA segments in a single plasmid was used as control [9]. The plasmid, pCassQ123, containing all three CMV RNA segments in a single plasmid and each driven by the 35S promoter was a gift from Dr. ShouWei Ding, UC Riverside.

In order to construct the CMV MP 33 amino acid deletion mutants, we used PCR and the specific primer set (33delfwd and 33delrev, listed in Table 1). PCR products were eluted from an agarose gel and self ligated to make pCMVar 33 G 2, 6, 8, wt and pCMVar 33E 2, 6, 8, wt variants, respectively (Additional file 5: Figure S5). Table 2 shows the names, activities and genotypes for the expression system variants used in this paper.

Additional file 5. Figure S5. Construction of the pCMVar 33G and pCMVar 33E for MP 33 amino acid deletion constructs.

Format: TIFF Size: 1.7MB Download fileOpen Data

Table 2. Nomenclature and composition of CMV-based systems


Binary plasmids purified from E. coli cultures were transformed into Agrobacterium tumefaciens GV3101 or EHA105 cells using electroporation. Transformed A. tumefaciens cells were plated on Luria-Bertani plates containing Rifampicin (10 μg/ml) and Gentamycin (20 μg/ml) for GV3101 and Kanamycin (50 μg/ml) for specific constructs, and Rifampicin (10 μg/ml) and Tetracycline (10 μg/ml) for EHA105 and Gentamycin (20 μg/ml) for specific constructs, respectively. For agroinfiltration, a single colony was inoculated into 5 ml L-MESA media (100 ml LB broth, 2 ml 0.5 M MES (pH 5.7), 20 μl 0.1 M acetosyringone) and grown to an OD600 of 1.0. Cells were harvested by centrifuging for 10 min at 3,500 g and resuspended in induction media (50 ml sterile dH20, 0.5 ml 1 M MgCl2, 1 ml 1 M MES (pH 5.7), 50 μl 0.1 M Acetosyringone), and allowed to sit at room temperature for 3 hrs before infiltration. When mixtures of A. tumefaciens cells were infiltrated into plants, cultures were prepared separately in induction medium and combined immediately before infiltration. For inoculating small sugar pumpkin plants, A. tumefaciens cells containing the constructs were infiltrated into N. benthamiana plants. Leaves were harvested 6 days after infiltration, and used for standard rub inoculation.

RNA extraction and realtime RT-PCR

Samples for RNA and protein extraction were harvested from infiltrated and non-infiltrated leaves at 6 days after infiltration. Total RNA was extracted using the RNeasy kit (QIAGEN Inc., U.S.A.) following the manufacturer’s instructions. Complementary DNA (cDNA) synthesized from DNase-digested total RNA was used for reverse transcription using the RNA 3end primer as listed in Table 1 and SuperScript II Reverse Transcriptase, as described by the manufacturer (Invitrogen, Carlsbad, CA, U.S.A.). Realtime PCR was performed using gene specific primers for each CMV RNA segment (realrna1fwd and realrna1rev for RNA 1, realrna2fwd and realrna2rev for RNA 2, realrna3onlyfwd and realrna3onlyrev for RNA 3, realrna4onlyfwd and realrna4onlyrev for RNA 4, and real18Sfwd, real18Srev for endogenous 18S control, respectively as listed in Table 1). Real-time PCR was performed using SYBR Green PCR master mix (Applied Biosystems, Life Technologies Corporation, Carlsbad, CA, U.S.A.) in an ABI Prism 7500 Sequence Detection system (Applied Biosystems, Life Technologies Corporation, Carlsbad, CA, U.S.A.) under standard amplification conditions (95°C for 5 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min). The threshold cycle (CT) is defined as the fractional cycle number at which the fluorescence exceeded the fixed threshold. Statistical analyses were performed using the Bonferroni (Dunn) t test using the SAS 9.1 program.

Protein extraction and immunoblotting

Proteins were extracted from leaves using protein extraction buffer (100 mM Tris–HCl (pH 8.0), 10 mM EDTA, 5 mM DTT, 150 mM NaCl, 0.1% Triton X-100, 1X protease inhibitor (Roche diagnostics, Germany) and tissue maceration using a bead-beater. Samples were centrifuged at 12,000 g for 20 min to remove cell debris, and protein concentrations were determined by Bradford assay using Coomassie Plus (Pierce, Thermo Scientific, IL, U.S.A.) with bovine serum albumin as the standard. Proteins were analyzed by SDS-PAGE in 12% polyacrylamide gels and transferred to Hybond-C Extra membranes (Amersham Pharmacia Biotech, U.K.). Membranes were incubated with rabbit CMV anti-CP polyclonal antibody at 1:2,500 dilution, followed by goat anti-rabbit IgG-alkaline phosphatase conjugate (Bio-Rad, Hercules, CA, U.S.A.) at 1:2,500 dilution. For E1 detection, membranes were incubated with specific mouse monoclonal IgG anti-E1 antibody (provided by Bill Adney, National Renewable Energy Lab) at 1:2,500 dilution, followed by goat anti-mouse IgG alkaline phosphatase conjugate (Bio-Rad, Hercules, CA, U.S.A.) at 1:2,500 dilution. After washing with Tris-buffered saline (100 mM Tris-Cl, pH 7.5, 0.9% NaCl) with 0.3% Tween-20 for three times, the membrane was developed to a purple color using colorimetric AP conjugate substrate reagent kit (Bio-Rad, Hercules, CA, U.S.A.) including premixed BCIP (5-bromo-4-chloro-3-indolyl phosphate) and NBT (nitroblue tetrazolium) substrate solutions (Bio-Rad, Hercules, CA, U.S.A.).

Endoglucanase (E1) activity assays

Endoglucanase (E1) activity assays were done as described [16]. A 60 μl aliquot of diluted supernatant containing E1 was added to 540 μl of acetate buffer (200 mM acetate, pH 5.5, 100 mM NaCl) and 200 μl of substrate (500 μM methylumbelliferyl-tagged cellobiose (MUC)). Then, 200 μl of the reaction was sampled at time zero and after 30 min, and added to 800 μl of stop buffer (150 mM glycine, pH 10). The change in fluorescence as released methylumbelliferine (MU) over time was measured with a VersaFluor fluorometer (Bio-Rad, Hercules, CA, U.S.A.). Fluorescence was converted to activity, and specific activity was determined as described [16].


Modified RNA4 leader sequences affect mRNA and coat protein levels

To facilitate cloning desired genes into the CMV CP region, we first created a separate CMV RNA 3-based plasmid and modified the intergenic nucleotide sequence upstream of the CP ORF start codon to contain desired restriction endonuclease sites (Figure 1). This also resulted in changes to the mRNA 4 nucleotide leader sequence immediately preceding the AUG start codon and therefore could affect mRNA translation efficiency [18-20]. Therefore, we first compared the respective CMVin and CMVar variants for their ability to replicate and to express CMV CP within infiltrated leaves. We used real-time PCR to quantify levels of progeny RNAs 1, 2, 3, and 3 plus 4 (because RNA 4 is a subset of RNA 3 and is therefore difficult to differentiate from RNA 3).

When we compared the CMVinII variants with CMViva, all showed accumulation of genomic and subgenomic RNAs, and of CMV CP (Figure 2A). Because we are most interested in protein production from RNA 4, comparison of the RNA 3 & 4 data show that the modified variants (CMVinII 2, 6 and 8) all showed slightly more RNAs 3 and 4 than did the wildtype CMVinII, but none were higher than CMViva (Figure 2A). Although the levels of RNAs 3 and 4 were not statistically different, comparison of CMV CP accumulation showed more CMV CP was detected for CMVinII variants 2, 6, 8 and CMViva, than was for the wildtype CMVinII. CMViva and CMVinII variants both have 46 nucleotide deletions in the inducible CMV RNA 1 such that although it is transcribed and the resulting RNA 1 serves for translation to yield the 1a protein, the RNA 1 genome segment is not replicated as are genome segments RNAs 2 and 3 (Additional file 2: Figure S2). Because the 1a component of the replicase complex is under the control of a relatively tightly regulated chemically inducible promoter, the recombinant viral amplicons are only produced under induction conditions.

thumbnailFigure 2. Relative RNA and coat protein accumulation levels for CMVinII and CMVarII variants having wt or modified RNA 4 leader sequences. After 6 days post-infiltration, infiltrated leaves were harvested and total RNAs and proteins were extracted as described in Methods. For CMVinII variants (see Table 2), estradiol was applied 18 hrs after infiltration using a cotton swab. For CMVinII variants, two leaves each from 3 plants for each treatment (n = 6) were used for 1st, 2nd biological trials, and three leaves each from 2 plants for 3rd, 4th trials (n = 6) yielding four different biological trials (total n = 24). For CMVarII variants (see Table 2), two leaves each from 3 plants for each treatment (n = 6) were used for analysis. These experiments were replicated three times (total n = 18). For immunoblot analysis, each lane was loaded with 15 μg of total protein. Real-time PCR reactions were performed using an ABI 7500 with gene specific primer sets. Relative Ct values were calculated to the respective 18S rRNA relative concentration. Relative folds were calculated to the repective wildtype CMVinII and CMVarII value, respectively. Group superscript letters next to the numbers represent different statistical groups, means with the same letter are not significantly different by the Bonferroni (Dunn) t test using the SAS 9.1 program. Panel (A) CMVinII variants; H , healthy uninfiltrated leaf; pR1R2, pCMVinII RNA 1 and RNA 2 only; CMVinII wt , wt leader; CMVinII 2 , #2 leader; CMVinII 6, #6 leader; CMVinII 8 , #8 leader; CMViva, pCMV (see Methods). Panel (B) CMVarII variants; H, healthy, uninfiltrated leaf; R1 + R2, pCMVarII RNA 1 and RNA 2 only; CMVarII wt , wild type leader; CMVarII 2 , #2 leader; CMVarII 6 , #6 leader; CMVarII 8, #8 leader; pQ123, pCassQ123 (see Methods).

When we compared the CMVarII variants, all showed accumulation of all CMV RNAs, and so long as inocula contained all three CMV genomic RNAs, accumulation of RNAs 1, 2 and 3 was not significantly different for the different variants. However, realtime PCR analysis showed lower accumulation of RNAs 3 + 4 for CMVarII variant6 when compared to the monopartite pQ123 (Figure 2B). All CMVarII variants showed much less CP accumulation than was seen for pQ123, and CMVarII 2, 6 and 8 showed less CP than did CMVarII wt (Figure 2B). However, all CMVarII variants were able to initiate systemic infections in N. benthamiana and zucchini squash plants (Additional file 6: Figure S6). RT-PCR and nucleotide sequence analysis of the CMV progeny showed that the modified leader sequences were retained in RNAs extracted from systemically-infected leaves (data not shown).

Additional file 6. Figure S6. Systemic symptoms in plants for CMVar II variants.

Format: TIFF Size: 555KB Download fileOpen Data

CMVinII and CMVarII variants yield high GFP fluorescence

To assess foreign protein production we first cloned the gene for GFP into the CP coding region for the CMVinII and CMVarII variants. Non-transgenic N. benthamiana plants were infiltrated and leaves were examined for fluorescence at 6 and 10 days post-infiltration. At 6 days post-infiltration bright GFP fluorescence was seen in the infiltrated regions (Figure 3). In general, the regions of the leaves infiltrated with CMVinII and CMVarII variants showed very bright fluorescence. By 10 days post-infiltration, bright GFP fluorescence was observed for the CMVinII and CMVarII variants, regardless of leader sequence. Despite the fact that CMVarII variants producing the CMV CP spread within plants giving systemic infections, CMVarII variants producing GFP did not, and fluorescence was localized to the infiltrated areas. This is most likely because these variants do not produce CMV CP, which is known to be a determinant of CMV systemic spread in plants [21,22], and thus these infections were localized to the infiltrated regions of the treated leaves. We also tested another reporter protein, the red fluorescent protein (RFP), for expression using CMVinII and CMVarII and obtained essentially identical results to those shown for the variants expressing GFP (data not shown).

thumbnailFigure 3. GFP fluorescence for CMVinII and CMVarII wt and leader sequence variants in N. benthamiana plants.CMVinII G and CMVarII G (see Table 2) columns are indicated for both 6 and 10 days after infiltration. Rows show relative GFP fluorescence for leader sequence variants. A. tumefaciens cells containing respective plasmids were mixed just before leaf infiltration. CMVinII G plants then had estradiol induction treatments 18 hrs after infiltration. Photos were taken under long wavelength UV light.

E1 was produced in plants using both CMVinII and CMVarII variants

Our intent is to develop easy-to-use CMV variants that give efficient production of desirable proteins in non-transgenic plants, including proteins with potential biofuel applications. Therefore, we next assessed E1 accumulation in leaves of infiltrated N. benthamiana plants. We first used immunoblot analysis to detect total E1 accumulation in leaves infiltrated with the CMVinII and CMVarII variants. E1 was detected in the infiltrated leaves for both CMVinII and CMVarII wild type variants (Figure 4). The leader sequence CMVinII variants 6 and 8 showed higher E1 compared to the wildtype CMVinII. For CMVarII variants, the wild type showed higher E1 accumulation, but the 6 and 8 variants also gave good E1 accumulation (Figure 4). Interestingly, the intact E1 migrated as a ca. 72 KDa protein as shown in Figure 4 and Additional file 7: Figure S7, even though the calculated MW of E1 is 57.3 KDa, including the histidine tag and rice amylase signal peptide (See Figure 1A). Similar reports for anomalous E1 migration in SDS-PAGE have been previously reported [16,23].

Additional file 7. Figure S7. Immunoblot analysis of E1 produced in infiltrated N. benthamiana leaves for CMVar I E and CMVar II E variants.

Format: TIFF Size: 555KB Download fileOpen Data

thumbnailFigure 4. Immunoblot analysis of E1 produced in infiltrated N. benthamiana leaves. N. benthamiana leaves were co-infiltrated with A. tumefaciens containing plasmids corresponding to the CMVinII E and CMVarII E variants (see Table 2) shown. CMVinII E leaves were treated with estradiol 18 hrs after infiltration. Leaves were harvested 6 days post-infiltration. Soluble proteins were extracted as described in Methods and concentrations were determined by Bradford assay. Numbers above each lane correspond to the specific RNA 3 variant used. Each sample represents 15 μg total protein extract per lane. Prestained size marker (Benchmark, Invitrogen, Carlsbad, CA, U.S.A.) shows 80 kDa band.

The immunoblot experiments showed E1 protein accumulation but our interest is in production of enzymatically active E1. Therefore we used activity assays on plant extracts to estimate yields of active E1. In repeated experiments, the CMVinII E6 and E8 consistently yielded 8 to almost 15 fold higher relative E1 accumulation than wildtype CMVinII E, while the yield for CMVinII E2 was negligible. By contrast, the wildtype CMVarII E consistently yielded more E1 than the other CMVarII variants (Table 3). CMVarII E2 gave negligible E1 accumulation while CMVarII E6 and E8 showed low yields, but much less than wildtype CMVarII E. We had anticipated that CMVarII would give higher protein accumulation in plants because of RNA 1 replication, which is lacking in CMVinII (Additional file 2: Figure S2), but this proved not to be the case, the highest overall yields were obtained with CMVinII E 6 and 8. The CMVarII is easier to use since there is no requirement for adding the RNA 1 inducer, estradiol, and if we could achieve higher protein accumulation with CMVarII this would be our choice. Therefore we next attempted to increase CMVar-driven protein accumulation by two additional approaches: to increase CMV RNA replication and to increase CMV spread within plants.

Table 3. Amount of active E1 (μg/g FW) in infiltrated N. benthamiana leaves using the different CMVin and CMVar leader sequence variants

Reassortant CMVarI variants yield more protein compared to CMVarII variants

CMV is one of the world’s most widespread plant viruses, and has many genetic variants which are primarily divided into the taxonomic subgroups I and II [5]. In general, subgroup I CMVs show more severe symptoms in plants than do subgroup II CMV isolates, which can show mild or even symptomless infections. This is suggested to be associated with the 2b protein (encoded by RNA 2) as a silencing suppressor [24], and effects can vary in different plant hosts [25]. Therefore, we generated and compared CMV subgroup I and II genomic reassortants for their abilities to give greater replication and protein production. All reassortants contained the same CMV subgroup II wildtype RNA 3 or variant constructs for GFP or E1. GFP fluorescence was brighter for all CMVarI variants compared with the respective CMVarII variants (Figure 5). We next compared production of active E1 among the CMVarI and II E variants by immunoblotting (Additional file 7: Figure S7) and found that the reassortant wildtype CMVarI E gave more active E1 than did CMVarII E in side-by-side experiments (Table 3 and Additional file 7: Figure S7). By contrast, CMVarI E variants 2, 6 and 8 gave very low E1 accumulation. However, wildtype CMVarI E gave relatively high E1 accumulation, similar to that for CMVinII E variants 6 and 8.

thumbnailFigure 5. Comparison of GFP fluorescence from CMVarI G and CMVarII G variants. N. benthamiana leaves were co-infiltrated with A. tumefaciens containing plasmids corresponding to the CMVarI and II G variants (see Table 2) as shown at Panel A. Numbers for leaves in panel at right indicate specific RNA 3 variant. Photographs were taken 6 days post-infiltration under UV light shown as Panel B.

The MP C-terminal 33 amino acid deletion constructs showed increased yields compared to the intact MP constructs

CMV requires both the MP and CP for cell-to-cell movement in plants, both of which are encoded by RNA 3 [5,26]. Thus for both CMVar and CMVin variants, when foreign sequences are cloned into the CP coding region, there is no cell-to-cell movement due to lack of the CMV-encoded CP, and the desired recombinant proteins (GFP or E1) accumulate only in the initially-infected cells. However, it was shown previously that when the CMV MP was mutated so as to lack the C-terminal 33 amino acids, CMV infections were able to move cell-to-cell in plants even in the absence of CP [27]. Therefore, we deleted the MP C-terminal 33 amino acids and compared E1 and GFP accumulation in plants using the CMVarI and CMVarII variants. GFP fluorescence was high for all variants with the 33 amino acid truncated MP (Figure 6). However, comparing E1 accumulation for all variants, the highest levels of active E1 were obtained for the 33 amino acid truncated CMVarI Ewt variant (Table 3). Our assays were for intact, enzymatically active E1, and we obtained yields up to 21 μg/g of active E1, corresponding to ~0.4% of TSP. Furthermore, unlike for the wildtype MP variants, the CMVinII 33E variants 6 and 8 gave relatively low accumulation of E1.

thumbnailFigure 6. Comparison of GFP fluorescence CMVarI 33 G and CMVarII 33 G MP deletion mutants. N. benthamiana leaves were co-infiltrated with A. tumefaciens containing plasmids corresponding to the CMVarI and II 33 G variants (see Table 2) as shown at left Panel A. Numbers for leaves in Panel B at right indicate specific RNA 3 variant containing MP deletion. Photographs were taken 6 days post-infiltration under UV light shown as Panel B.


Several different viruses have been used for protein production in plants, and each has advantages as well as disadvantages [28-32]. Many of the “first generation” plant virus vectors [28,33] utilized whole plant systemic virus infections to give desired proteins. While many of these have proven to be very useful there are some significant drawbacks. Systemic infections can take several days to fully develop. Protein production is then asynchronous and yields can vary in different tissues [3]. Recombinant viruses also show size constraints for the inserted sequence, often coding sequences of only 1 kb or less (encoding a protein of only ~35 kDa) can be inserted [34]. Then as the infection develops the viruses partially or completely excise the inserted recombinant sequence, leading to loss of the desired intact protein product [28,35]. Furthermore, some viruses (e.g. those with icosahedral capsids such as CMV) may have even more severe size constraints if RNA encapsidation is a requirement for development of the systemic infection. Then if the coding sequence for the desired protein is large, insertion into the viral RNA may preclude encapsidation, thereby preventing efficient spread.

Recent progress in developing Agrobacterium tumefaciens delivered plant virus-based protein production systems has been made by several research groups using different plant viruses [31,34,36]. These plant virus-based amplicon systems offer many advantages including the fact that non-transgenic plants can be used, the desired protein production is rapid, the product can accumulate to high levels, and virus-based expression can be temporally regulated to be almost synchronous in all infiltrated areas. Because a majority of the infiltrated cells become simultaneously infected, virus movement to new cells is not necessary, encapsidation of recombinant RNAs is not an issue. These “second generation” virus-based systems also can retain larger foreign coding sequences and thus produce larger proteins in plants [34], here we produced enzymatically active 56,000 MW E1.

In our previous work, we used the estradiol-inducible, CMV-based CMViva to produce α anti-trypsin (AAT) in non-transgenic N. benthamiana plants [9]. CMViva has all three CMV genome components in one large 28 kbp plasmid, which, due to its large size is difficult to manipulate. Thus, here we took approaches to develop CMV-based inducible (CMVin) as well as autonomously replicating (CMVar) systems, both of which are more easily manipulated and might be able to give high accumulation of heterologous proteins in plants. First, we separated the CMV genomic RNA cDNAs onto two plasmids, one containing the RNA 1 and 2 replication-associated genome components and the other containing the CMV RNA 3 genome segment. The CMV RNA3 component is rather small in size, 2.2 kb, and is easy to manipulate and to engineer to contain restriction enzyme sites to allow for easy removal of the CMV CP gene and replace it with any gene of interest. The desired restriction enzyme sites were introduced into the intergenic region of RNA 3. As expected, these altered the 5′ untranslated leader sequence of the resulting mRNA (RNA 4). The sgRNA promoter (for RNA 4 transcription) is within the minus strand of RNA 3 and is recognized by the RNA-dependent RNA polymerase and mRNA transcription is initiated. For CMV-Q RNA3, the transcription initiation starts at nt position 1167 in the intergenic region, which is upstream of the modified leader sequences. Our analyses demonstrated that the RNA 3 modifications affected RNA 3 and RNA 4 accumulation, but showed even more unpredictable effects on resulting protein accumulation. It does not appear that these can be attributed only to start codon context [18,19] as the same construct (RNA 3) showed different protein yields whether the RNA was delivered using CMVin vs.CMVar.

In contrast to CMViva, both CMVinII and CMVarI and II variants require mixing A. tumefaciens cells containing different plasmids which are then co-infiltrated into plants and T-DNA from the different A. tumefaciens cells containing the CMV plasmids must be transferred to the same plant cell for the complete CMV amplicon. For CMVinII variants this is then followed by induction using estradiol, which resulted in high level accumulation of the proteins tested here (CP, GFP, E1). However, like for CMViva, the CMVinII RNA 1 deletion does not allow for its replication, only translation of the newly transcribed mRNA. Therefore we also developed the non-inducible autonomously replicating CMV-based system, CMVarI and II. Wildtype CMVar (expressing the CMV CP) replicated to very high levels and even caused systemic infections in plants. However, when genes for GFP or E1 were substituted for the CP gene, both proteins were produced in plants within the infiltrated areas, and quantitative analyses showed that high levels of proteins accumulated for both CMVin vs.CMVar, particularly at 6 days post-infiltration.

Although CMVinII E 6 and 8 variants gave slightly more active E1 in most experiments, CMVarI and II variants offers advantages in ease of use (e.g. no need to add the inducer) and thus, two additional approaches to improve accumulation of the desired protein product were investigated. Like most viruses having genomes composed of multiple segments, CMV genomic RNAs can be mixed (reassortment) to achieve genetic diversity [37,38], and this offers opportunities for using CMV to produce desirable proteins in different plant species, as has been demonstrated also by others [3]. Therefore, we generated CMV reassortant genotypes by substituting CMV subgroup I genomic RNAs 1 and 2 derived from a more virulent CMV, with the original CMV Q subgroup II RNA 3, giving CMVarI. Comparison of CMVarI and CMVarII G, E variants showed higher GFP and E1 for CMVarI G, E variants. However, the CMVarI Ewt showed higher E1 accumulation than did the corresponding CMVinII Ewt, but CMVinII E variants 6 and 8 gave the higher E1 accumulation than CMVar I 6 and 8 variants thus showing that reassortment alone was not sufficient.

As another alternative, we generated a MP C-terminal 33 amino acid deletion mutant. Cell-to-cell movement in CMV-infected plants requires interactions between the CP and MP [22]. Our CMV-based systems including CMViva, CMVarI and II and CMVinII are cell-to-cell movement deficient since they lack the CP and thus, desired recombinant proteins are produced only within infiltrated cells. However, previous workers demonstrated that the CMV MP C-terminal 33 amino acids are essential to recognize and interact with the CP [26]. When this region is deleted, the CMV infections can spread cell-to-cell even in the absence of CP [27]. In support of this the CMVarI and CMVarII 33 G variants showed high CMV-based GFP production (Figure 6; and see [4]). When we created MP 33 amino acid deletion constructs and tested them, they showed increased production of not only GFP in CMVarI and II 33 G variants, but also of E1 in CMVarI and II 33E variants (Table 3, Figures 5 and 6), and the highest yields of active E1 were obtained using the CMVarI 33E variants.

Other workers have produced versions of E1 in various transgenic plants with gene expression driven by different promoters. For example, full-length E1 containing the catalytic domain, linker and carbohydrate binding domain has been previously produced in transgenic tobacco plants. Based on the resulting E1 activity, yields of up to 0.25% on average of total leaf soluble proteins were shown with Mac promoter, a chimeric promoter of the CaMV 35S and mannopine synthase gene [11]. Similar yields were shown also with CaMV 35S promoter [13]. In transgenic Z. mays seeds, the full-length E1 was produced using Glob-1 (Maize embryo-preferred globulin-1 promoter) and yields up to 6% TSP were obtained [39]. In transgenic rice (Oryza sativa) plants, 35S driven E1 lacking the carbohydrate binding domain but only containing the catalytic domain gave yields up to 4.9% TSP [40]. Thus, our yields of up to 0.4% TSP of intact E1 in nontransgenic N. benthamiana plants are similar to those achieved for intact E1 in transgenic tobacco, but less than those in more specialized systems. Furthermore, CMVin and CMVar-based production of the desired protein can be temporally regulated to give almost synchronous protein accumulation over a very short time period, even a few days.


Our data demonstrate that the CMV-based systems, CMVin and CMVar, are good candidates for production of desired heterologous proteins in nontransgenic plants. Our modifications described here, including manipulating cloning sites for foreign gene introduction, enhance the ease of their use, and reassortant genotypes and CMV movement protein deletions also allow for greater protein accumulation. Also, N. benthamiana, which is particularly suitable for agro infiltration, is a very good plant for protein production, but due to the wide host range of CMV, other plants may also prove to be useful for production of different proteins.


CMV: Cucumber mosaic virus; TMV: Tobacco mosaic virus; E1:Acidothermus cellulolyticus endo-1, 4-β-glucanase; GFP: Green fluorescent protein; CP: Coat protein; ORF: Open reading frame; MP: Movement protein; FW: Fresh weight; TSP: Total soluble protein; RFP: Red fluorescent protein.

Competing interests

The authors declare that they have no competing interests.

Author’ contributions

MSH was responsible for experiment design, execution, analysis and wrote the manuscript. BEL was responsible for experimental execution including enzymatic activity assays and interpretation. KAM helped to conceive the study, discussed, and helped edit the manuscript. BWF helped to conceive the study, helped with organizing the experimental work, data interpretation, and helped to write and edit the manuscript. All authors read and approved the final manuscript.


We are extremely grateful to Dr. John Lindbo and to Dr. Mysore Sudarshana for many helpful discussions. We are especially grateful to Bill Adney, Senior Scientist at the National Renewable Energy Lab, for providing the E1 antibody. We also thank Dr. ShouWei Ding, University of California, Riverside, for the gift of pCassQ123. This work was supported in part by Chevron Technology Ventures, a division of Chevron, U.S.A., Inc; and NSF CBET-1067432.


  1. Giddings G, Allison G, Brooks D, Carter A: Transgenic plants as factories for biopharmaceuticals.

    Nat Biotechnol 2000, 18:1151-1155. PubMed Abstract | Publisher Full Text OpenURL

  2. Miele L: Plants as bioreactors for biopharmaceuticals: regulatory considerations.

    Trends Biotechnol 1997, 15:45-50. PubMed Abstract | Publisher Full Text OpenURL

  3. Matsuo K, Hong JS, Tabayashi N, Ito A, Masuta C, Matsumura T: Development of Cucumber mosaic virus as a vector modifiable for different host species to produce therapeutic proteins.

    Planta 2007, 225(5):277-286. PubMed Abstract | Publisher Full Text OpenURL

  4. Fujiki M, Kaczmarczyk JF, Yusibov V, Rabindran S: Development of a new cucumber mosaic virus-based plant expression vector with truncated 3a movement protein.

    Virology 2008, 381:136-142. PubMed Abstract | Publisher Full Text OpenURL

  5. Palukaitis P, García-Arenal F: Cucumoviruses.

    Adv Virus Res 2003, 62:241-323. PubMed Abstract OpenURL

  6. Buck K: Comparison of the replication of positive-stranded RNA viruses of plants and animals.

    Adv Virus Res 1996, 47:159-251. PubMed Abstract OpenURL

  7. Lucy AP, Guo HS, Li WX, Ding SW: Suppression of post-transcriptional gene silencing by a plant viral protein localized in the nucleus.

    EMBO J 2000, 19(7):1672-1680. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  8. Fukuzawa N, Ishihara T, Itchoda N, Tabayashi N, Kataoka C, Masuta C, Matsumura T: Risk-managed production of bioactive recombinant proteins using a novel plant virus vector with a helper plant to complement viral systemic movement.

    Plant Biotechnol J 2011, 9(1):38-49. PubMed Abstract | Publisher Full Text OpenURL

  9. Sudarshana MR, Plesha MA, Uratsu SL, Falk BW, Dandekar AM, Huang TK, McDonald KA: A chemically inducible cucumber mosaic virus amplicon system for expression of heterologous proteins in plant tissues.

    Plant Biotechnol J 2006, 4:551-559. PubMed Abstract | Publisher Full Text OpenURL

  10. Zuo J, Niu Q-W, Chua N-H: An estrogen receptor-based transactivator XVE mediates highly inducible gene expression in transgenic plants.

    The Plant Journal 2000, 24:265-273. PubMed Abstract | Publisher Full Text OpenURL

  11. Dai Z, Hooker BS, Quesenberry RD, Thomas SR: Optimization of Acidothermus cellulyticus endoglucanase (E1) production in transgenic tobacco plants by trnascriptional, post-transcription and post-translational modification.

    Transgenic Res 2005, 14:627-643. PubMed Abstract | Publisher Full Text OpenURL

  12. Ransom C, Balan V, Biswas G, Dale B, Crockett E, Sticklen M: Heterologous Acidothermus cellulolyticus 1,4-beta-endoglucanase E1 produced within the corn biomass converts corn stover into glucose.

    Appl Biochem Biotechnol 2007, 137:207-219. PubMed Abstract | Publisher Full Text OpenURL

  13. Ziegelhoffer T, Raasch J, Austin-Phillips S: Expression of Acidothermus cellulyticus E1 endo-beta-1,4-glucanase catalytic domain in transplastomic tobacco.

    Plant Biotechnol J 2009, 7:527-536. PubMed Abstract | Publisher Full Text OpenURL

  14. Ding S-W, Rathjen JP, Li W-X, Swanson R, Healy H, Symons RH: Efficient infection from cDNA clones of cucumber mosaic cucumovirus RNAs in a new plasmid vector.

    J Gen Virol 1995, 76:459-464. PubMed Abstract | Publisher Full Text OpenURL

  15. Xiang C: A mini binary vector series for plant transformation.

    Plant Mol Biol 1999, 40:711-717. PubMed Abstract | Publisher Full Text OpenURL

  16. Lindenmuth BE, McDonald KA: Production and characterization of Acidothermus cellulyticus endoglucanase in Pichia pastoris.

    Protein Expr Purif 2011, 77:153-158. PubMed Abstract | Publisher Full Text OpenURL

  17. Lin HX, Rubio L, Smythe A, Jiminez M, Falk BW: Genetic diversity and biological variation among California isolates of Cucumber mosaic virus.

    J Gen Virol 2003, 84:249-258. PubMed Abstract | Publisher Full Text OpenURL

  18. Kozak M: Alternative ways to think about mRNA sequences and proteins that appear to promoter internal initiation of translation.

    Gene 2003, 318:1-23. PubMed Abstract | Publisher Full Text OpenURL

  19. Kozak M: Regulation of translation via mRNA structure in prokaryotes and eukaryotes.

    Gene 2005, 361:13-37. PubMed Abstract | Publisher Full Text OpenURL

  20. Nakamoto T: Evolution and the universality of the mechanism of initiation of protein synthesis.

    Gene 2009, 432(1–2):1-6. PubMed Abstract | Publisher Full Text OpenURL

  21. Taliansky ME, Garcia-Arenal F: Role of cucumovirus capsid protein in long distance movement within the infected plant.

    J Virol 1995, 69:916-922. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  22. Boccard F, Baulcomb D: Mutational anaysis of cis-acting sequences and gene function in RNA3 of cucumber mosaic virus.

    Virology 1993, 193:563-578. PubMed Abstract | Publisher Full Text OpenURL

  23. Sakon J, Adney WS, Himmel ME, Thomas SR, Karplus PA: Crystal structure of thermostable family 5 endocellulase E1 from Acidothermus cellulolyticus in complex with cellotetraose.

    Biochemistry 1996, 35:10648-10660. PubMed Abstract | Publisher Full Text OpenURL

  24. Shi BJ, Palukaitis P, Symons RH: Differential virulence by strains of Cucumber mosaic virus is mediated by the 2b gene.

    Mol Plant Microbe Interact 2002, 15:947-955. PubMed Abstract | Publisher Full Text OpenURL

  25. Du Z-Y, Chen F-F, Liao Q-S, Zhang H-R, Chen Y-F, Chen J-S: 2b ORFs encoded by subgroup IB strains of cucumber mosaic virus induce differential virulence on Nicotiana species.

    J Gen Virol 2007, 88:2596-2604. PubMed Abstract | Publisher Full Text OpenURL

  26. Canto T, Prior DAM, Hellwald KH, Oparka KJ, Palukaitis P: Characterization of Cucumber mosaic virus IV. Movement protein and coat protein are both essential for cell-to-cell movement of Cucumber mosaic virus.

    Virology 1997, 237:237-248. PubMed Abstract | Publisher Full Text OpenURL

  27. Nagano H, Mise K, Furusawa I, Okuno T: Conversion in the requirement of coat protein in cell-to-cell movement mediated by the Cucumber mosaic virus movement protein.

    J Virol 2001, 75:8045-8053. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  28. Choi IR, Stenger DC, Morris TJ, French R: A plant virus vector for systemic expression of foreign genes in cereals.

    Plant J 2000, 23:547-555. PubMed Abstract | Publisher Full Text OpenURL

  29. Regnard GL, Halley-Stott RP, Tanzer FL, Hitzeroth II, Rybicki EP: High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector.

    Plant Biotechnol J 2010, 8(1):38-46. PubMed Abstract | Publisher Full Text OpenURL

  30. Jiang L, Li Q, Li M, Zhou Z, Wu L, Fan J, Zhang Q, Zhu H, Xu Z: A modified TMV-based vector facilitates the expression of longer foreign epitopes in tobacco.

    Vaccine 2006, 24(2):109-115. PubMed Abstract | Publisher Full Text OpenURL

  31. Cañizares MC, Nicholson L, Lomonossoff GP: Use of viral vectors for vaccine production in plants.

    Immunol Cell Biol 2005, 83:263-270. PubMed Abstract | Publisher Full Text OpenURL

  32. Sainsbury F, Thuenemann EC, Lomonossoff GP: pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants.

    Plant Biotechnol J 2009, 7(7):682-693. PubMed Abstract | Publisher Full Text OpenURL

  33. Gleba Y, Klimyuk V, Marillonnet S: Magnifection-a new platform for expressing recombinant vaccines in plants.

    Vaccine 2005, 23:2042-2048. PubMed Abstract | Publisher Full Text OpenURL

  34. Gleba Y, Klimyuk V, Marillonnet S: Viral vectors for the expression of proteins in plants.

    Curr Opin Biothechnol 2007, 18:134-141. Publisher Full Text OpenURL

  35. Dawson WO, Lewandowski DJ, Hilf ME, Bubrick P, Raffo AJ, Shaw JJ, Grantham GL, Desjardins PR: A tobacco mosaic virus-hybrid expresses and loses an added gene.

    Virology 1989, 172:285-292. PubMed Abstract | Publisher Full Text OpenURL

  36. Lindbo JA: TRBO: a high-efficiency Tobacco mosaic virus RNA-based overexpression vector.

    Plant Physiol 2007, 145:1232-1240. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  37. Chen Y, Chen J, Zhang H, Tang X, Du Z: Molecular evidence and sequence analysis of a natural reassortant between cucumber mosaic virus subgroup IA and II strains.

    Virus Genes 2007, 35:405-413. PubMed Abstract | Publisher Full Text OpenURL

  38. Boinnet J, Fraile A, Sacristán S, Malpica JM, García-Arenal F: Role of recombination in the evolution of natural populations of Cucumber mosaic virus, a tripartite RNA plant virus.

    Virology 2005, 332:359-368. PubMed Abstract | Publisher Full Text OpenURL

  39. Hood EE: Subcellular targeting is a key condition for high-level accumulation of cellulase protein in transgenic maize seed.

    Plant Biotechnol J 2007, 5:709-719. PubMed Abstract | Publisher Full Text OpenURL

  40. Oraby H, Venkatesh B, Dale B, Ahmad R, Ransom C, Oehmke J, Sticklen M: Enhanced conversion of plant biomass into glucose using transgenic rice-produced endoglucanase for cellulosic ethanol.

    Transgenic Res 2007, 16:739-749. PubMed Abstract | Publisher Full Text OpenURL